BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 223 filers reported holding BEAM THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,148,585 | -27.3% | 49,022 | +2.5% | 0.01% | -40.0% |
| Q1 2024 | $1,580,799 | +625.8% | 47,845 | +601.4% | 0.01% | +233.3% |
| Q2 2023 | $217,795 | -88.8% | 6,821 | -83.3% | 0.00% | -92.9% |
| Q3 2022 | $1,946,000 | +351.5% | 40,839 | +443.2% | 0.04% | +320.0% |
| Q1 2022 | $431,000 | -89.5% | 7,518 | -84.0% | 0.01% | -84.8% |
| Q3 2021 | $4,087,000 | +505.5% | 46,974 | +795.4% | 0.07% | +407.7% |
| Q2 2021 | $675,000 | – | 5,246 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.50% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |